At a glance
ClinicalIndex Comparison RecordN/ACompleted· 134 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
In Brief
An observational study for Von Willebrands Disease. Completed, enrolled 134 participants across 1 site.
Detailed Summary
The purpose of this study is to improve the investigators ability to diagnose von Willebrand Disease (VWD), a common inherited bleeding disorder. This study will look at a new screening blood test used to determine if a person has VWD. This new screening blood test can determine a diagnosis more rapidly than current blood tests. Also this test could be available at local hospital labs rather than require samples to be sent to bigger more specialized labs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVon Willebrands Disease
CountriesUnited States
CollaboratorsVersiti Blood Health
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartJul 2015
Primary CompletionDec 2021
Study CompletionJun 2022
TodayJul 2026
First PostedJun 9, 2015
Enrollment StartJul 1, 2015
Primary CompletionDec 31, 2021
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 11.1 years ago